LICENSE AGREEMENTLicense Agreement • May 10th, 2011 • Novavax Inc • Biological products, (no disgnostic substances) • New York
This License Agreement (the “Agreement”) is entered into as of December 9th, 2010 (“Signing Date”) by and between Novavax Inc., having its principal place of business at 9920 Belward Campus Drive, Rockville, MD 20850, USA (“NOVAVAX”) and LG Life Sciences, Ltd., having its principal place of business at LG Gwanghwamun Bldg., 92 Sinmunno 2-ga, Jongno-gu, Seoul, Republic of Korea (“LGLS”). NOVAVAX and LGLS may each be referred to as a “Party” and collectively as the “Parties.”
